Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Risk of Disseminated Cancer After Laparoscopic Hysterectomy Assessed in Report February 6, 2015 Irvin Jackson Add Your Comments A new study calls for more specific guidelines for use of power morcellators during laparoscopic hysterectomy surgeries, amid concerns that the devices can spread and disseminate cancer that is hidden in the uterus. In a report published in the American Journal of Obstetrics & Gynecology (ACOG) on February 5, researchers from the Irvine Medical Center at the University of California indicated that preoperative evaluation before uterine fibroid surgery should be used to determine whether a woman is eligible for a laparoscopic hysterectomy with morcellation. Power morcellators are medical devices increasingly used in recent years during minimally invasive hysterectomy and myomectomy procedures for uterine fibroids, allowing doctors to cut up the tissue and remove it through a small incision in the abdomen. This is designed to reduce recovery time, minimize scarring and avoid the risk of infections or other complications associated with traditional hysterectomy procedures. Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hysterectomy Morcellation Cancer Lawsuits Power morcellators used during a laparoscopic hysterectomy or uterine fibroid surgery may cause the spread of aggressive cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION This new call for more specific guidelines seems to contradict other reports that have suggested there is no way to make power morcellators safer and reliably evaluate the risk of disseminating cancer during laparoscopic hysterectomy procedures, given an inability to diagnose whether uterine fibroids are cancerous before they are removed. Researchers looked at data used in a number of studies involving morcellation during a laparoscopic hysterectomy for uterine fibroid removal, and determined that the overall quality of data is low, even in studies that helped the FDA determine that doctors should avoid using power morcellators for uterine fibroid removal in April 2014. Ultimately, the agency required new black box warnings on all power morcellators to alert doctors and patients of the risk of upstaging undiagnosed uterine sarcoma and leiomyosarcoma. The agency also contraindicated the use of power morcellators for most women. This latest study from researchers at Irvine Medical Center challenges those conclusions to some degree, and called for new, specific recommendations that would help doctors screen patients more effectively for power morcellation procedures. “There are limited data on the prevalence of sarcoma in morcellated specimens and even fewer cases and studies on the incidence of disseminated disease in patients who underwent minimally invasive surgical techniques with the use of power morcellation,” the study’s authors state. “Without reliable data, any recommendation on the safety of power morcellation is premature, given the known benefits of minimally invasive surgery on patient recovery and quality of life.” During FDA advisory panel meetings this summer, a panel of independent experts convened to evaluate the cancer dissemination risk with laparoscopic hysterectomies concluded that there is no way to make power morcellators safe, given the estimation that about one in 350 women who undergo uterine fibroid removal have undiagnosed uterine cancer. The panel could not decide whether power morcellators should all be recalled or whether they should all include a black box warning, which is what the FDA ultimately decided to do. “Specific guidelines for the use of power morcellation may be of benefit while awaiting advances in preoperative diagnosis of sarcomas. If preoperative evaluation raises suspicion for malignancy, morcellation clearly should be avoided,” the new study concludes. “Surgeons should review surgical alternatives that include laparotomy, mini-laparotomy, and colpotomy with possible manual morcellation vaginally or within an endoscopic bag.” In another study published by ACOG in December, researchers from Kaiser Permanente indicated that there were no risk factors which helped determine which women may be at risk of power morcellation cancer, and said no such guidelines are currently reliable. “There was no association between any of the factors analyzed and uterine sarcoma,” that study determined. “Uterine sarcoma was found in 0.6% of patients who underwent power morcellation but was not found to be significantly associated with any preoperative factors.” Laparoscopic Hysterectomy Cancer Lawsuits In recent months, many health experts called for power morcellator recalls to be issued and have recommended that doctors stop performing the minimally invasive, laparoscopic hysterectomy procedures involving morcellation. The Johnson & Johnson subsidiary Ethicon, which was previously responsible for manufacturing 70% of all power morcellators on the market, announced a that it will no longer manufacture morcellators, indicating that there is currently no way to make the devices safe. A number of hospital systems, doctors and health insurance companies have turned away from the procedures entirely, deeming power morcellation too risky for women. As more women and families learn about the link between the spread of cancer and hysterectomy procedures, a growing number of laparoscopic hysterectomy lawsuits over disseminated cancer have been filed against various manufacturers of these devices, alleging that inadequate warnings have ben provided for patients and the medical community for years. Plaintiffs allege that the rapid spread of leiomyosarcoma, endometrial stromal sarcoma or other uterine cancers may have been avoided if any number of different alternative treatment options available for women with symptomatic uterine fibroids had been used, including traditional surgical hysterectomy performed vaginally or abdominally, catheter-based blocking of the uterine artery, high-intensity focused ultrasound, drug therapy and laparoscopic hysterectomy or myomectomy without use of morcellation. Tags: Cancer, Hysterectomy, Leiomyosarcoma, Morcellation, Uterine Fibroid Removal, Uterine Sarcoma Image Credit: | More Morcellation Lawsuit Stories FDA Issues New Guidelines, Safety Communication On Use Of Power Morcellators February 26, 2020 Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019 CDC Weighs New Guidelines For Gynecologists For Detecting Uterine Cancer May 11, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: yesterday) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 3 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 4 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Morcellator Use Tied To Increased Risk Of Death In Women With Uterine Sarcoma: Study September 30, 2019
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: yesterday) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 3 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 4 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)